XML 39 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Common Stock
Voting Common Stock
Common Stock
Non-voting Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Convertible preferred stock, Beginning balance at Dec. 31, 2019   $ 36,595 $ 29,848            
Convertible preferred stock, Beginning balance (shares) at Dec. 31, 2019   11,736,119 7,628,846            
Beginning balance at Dec. 31, 2019 $ (49,412)           $ 1,085   $ (50,497)
Beginning balance (shares) at Dec. 31, 2019         3,161,653        
Issuance of common stock upon exercise of stock options $ 100           100    
Issuance of common stock upon exercise of stock options, (shares) 100,545       100,545        
Sale of stock, net of offering costs $ 166,630       $ 1   166,629    
Sale of stock, net of offering costs, (shares)         9,573,750        
Sale of convertible preferred stock, net of issuance costs     $ 29,942 $ 49,826          
Sale of convertible preferred stock, net of issuance costs (shares)     7,628,846 3,443,612          
Conversion of convertible preferred stock upon initial public offering 146,211 $ (36,595) $ (59,790) $ (49,826) $ 2 $ 1 146,208    
Conversion of convertible preferred stock upon initial public offering (shares)   (11,736,119) (15,257,692) (3,443,612) 19,327,052 11,110,371      
Stock-based compensation expense, including issuance of RSAs 5,583           5,583    
Stock-based compensation expense, including issuance of RSAs (shares)         432,301        
Net loss (56,929)               (56,929)
Ending balance at Dec. 31, 2020 212,183       $ 3 $ 1 319,605   (107,426)
Ending balance (shares) at Dec. 31, 2020         32,595,301 11,110,371      
Issuance of common stock upon exercise of stock options $ 3,504           3,504    
Issuance of common stock upon exercise of stock options, (shares) 995,950       995,950        
Sale of stock, net of offering costs $ 161,412       $ 1   161,411    
Sale of stock, net of offering costs, (shares)         2,583,334 291,666      
Issuance of common stock under ESPP 272           272    
Issuance of common stock under ESPP, (shares)         25,714        
Unrealized gain (loss) on marketable securities, net of tax (711)             $ (711)  
Stock-based compensation expense, including issuance of RSAs 20,931           20,931    
Net loss (111,694)               (111,694)
Ending balance at Dec. 31, 2021 $ 285,897       $ 4 $ 1 $ 505,723 $ (711) $ (219,120)
Ending balance (shares) at Dec. 31, 2021         36,200,299 11,402,037